Italy’s Angelini Said to Explore Catalyst Pharma Acquisition

Italy's Angelini Group is reportedly exploring the acquisition of Catalyst Pharma, a U.S.-based pharmaceutical company. The potential deal highlights strategic expansion in the pharmaceutical sector.